Clinical Trials Directory

Trials / Completed

CompletedNCT02387931

Supplementation in Adolescent Girls With Endometriosis

SAGE: Supplementation in Adolescent Girls With Endometriosis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
Female
Age
12 Years – 25 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.

Detailed description

This is a randomized controlled trial designed to evaluate the effect of dietary supplementation on endometriosis symptom remediation. Adolescent and young adults females aged 12 to 25 years with a surgically-confirmed diagnosis of endometriosis will be eligible for study participation. Subjects will be excluded if they have concurrent chronic illnesses that affect gastrointestinal absorption of nutrients (e.g., celiac disease, IBD, cystic fibrosis), a history of renal stones, are pregnant, or non-English speaking. Once consented, subjects will be randomized to one of 3 treatment assignments: 1) vitamin D3 2000 IU daily (n=30), 2) fish oil 1000 mg daily (n=30), 3) placebo (n=30) and will take these daily for 6 months. Baseline nutrient intake from food and supplements will be assessed using the Food Frequency Questionnaire (FFQ). The 142 item survey assesses usual dietary intake during the past year. Validated rating scales including the visual analog scale (VAS), SF-36, and the World Endometriosis EPHect questionnaires will be used to measure pain and overall quality of life. The SF-36 measures 8 health concepts relevant across disease groups, including limitations to physical or social activities because of health problems, vitality, and general health perception. Patients will complete a full review of medication usage, past medical history, family history, and other lifestyle factors. Anthropometrics will be measured, and vital signs obtained. Measures will be repeated at 3-month intervals for a total of 6 months. Blood will be drawn at baseline, and at 6 months to measure levels of fatty acids, vitamin D, parathyroid hormone (PTH), and calcium.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D3Nature Made Vitamin D 2000IU, 1 softgel taken daily
DIETARY_SUPPLEMENTFish OilNature Made ultra omega-3 mini fish oil 500mg, 2 soft gels taken daily
OTHERPlaceboPlacebo capsule, 2 taken daily

Timeline

Start date
2014-09-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-03-13
Last updated
2016-12-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02387931. Inclusion in this directory is not an endorsement.